Harm Reduction Journal

Article	Citations
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego–Tijuana border region	114
Decentralized HIV testing: comparing peer and mail-based distribution strategies to improve the reach of HIV self-testing among people who use drugs in Florida	100
Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study	60
Expanding single-venue services to better engage young people who inject drugs: insights from India	54
Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior	51
Managed alcohol: one community’s innovative response to risk management during COVID-19	48
The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework	47
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review	44
Contamination of a drug consumption room with drugs and potential risks for social health care workers	44
HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA	41
Welfare first: transforming harm reduction at UK festivals	40
Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment	39
Exploring perceived quality of life in long-term methadone-dependent patients: a qualitative study	39
Acceptability of supervised injection facilities among persons who inject drugs in upstate New York	38
Moving from ‘stigma reduction’ to ‘inclusion’: development of the inclusion collaborative at Nepean Blue Mountains Local Health District, New South Wales	38
Experiences of harm and mental ill-health among gay, bisexual and other men-who-have-sex-with-men who use methamphetamine or GHB/GBL in different combinations: findings from the COMeT study in Taiwan	37
Decolonizing drug policy	37
Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals “blind spots” in detection capabilities	37
A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City	37
Channelling and taxation in European online gambling markets: evolution and policy implications	34
Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study	34
Integration of a community-based harm reduction program into a safety net hospital: a qualitative study	29
Barriers to uptake of harm reduction techniques for GBMSM who use drugs in night-clubs and sex-on-premises venues in London and the Southeast: a mixed-methods, qualitative study	29
The implementation of safer drug consumption facilities in Scotland: a mixed methods needs assessment and feasibility study for the city of Edinburgh	29
Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use:	29

Facilitators of and obstacles to practitioners’ adoption of harm reduction in cannabis use: a scoping review	27
Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma	27
Vaping among Norwegians who smoke or formerly smoked: reasons, patterns of use, and smoking cessation activity	27
Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia’s drug supply	26
“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose	25
The war on drugs is a war on us: young people who use drugs and the fight for harm reduction in the Global South	25
Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis	25
Online interventions and virtual day centres for young people who use drugs: potential for harm reduction?	24
Will the Russian war in Ukraine unleash larger epidemics of HIV, TB and associated conditions and diseases in Ukraine?	24
“Expected to happen”: perspectives on post-release overdose from recently incarcerated people with opioid use disorder	23
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative	23
First results of the French OCTOPUS survey among festival attendees: a latent class analysis	23
Correction: Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys	22
Feeling safer: effectiveness, feasibility, and acceptability of continuous pulse oximetry for people who smoke opioids at overdose prevention services in British Columbia, Canada	22
A systematic review of interventions that impact alcohol and other drug-related harms in licensed entertainment settings and outdoor music festivals	22
Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada	22
Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study	22
Injections and infections: understanding syringe service program utilization in a rural state	21
Factors associated with gaps in naloxone knowledge: evidence from a 2022 great plains survey	21
Patient perspectives on naloxone receipt in the emergency department: a qualitative exploration	21
One-month alcohol abstinence national campaigns: a scoping review of the harm reduction benefits	21
Puff, Puff, Don’t Pass: harm reduction for cannabis use during a viral respiratory pandemic	20
Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up	20
Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand	20
Challenges for drug checking services in Scotland: a qualitative exploration of police perceptions	20
Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder	20
BeHERE’s effective virtual training to build capacity to support people who use drugs in non-substance use disorder settings	19
Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study	19
Assessing healthcare cost changes associated with transitioning away from cigarette smoking using healthcare claims data: an exploratory study among adult male patients with COPD	19
Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada	19
Analysis of different populations accessing online overdose response training and harm reduction supplies (ADORES)	19
Prevalence of HIV and Hepatitis C and access to opioid substitution treatment among people who inject drugs in three cities in Croatia: findings from the second wave of respondent-driven sampling surv	18
Structural stigma within inpatient care for people who inject drugs: implications for harm reduction	18
Not all screens are created equal: examination of surface features and other physical properties of commonly used screen materials for smoking drugs	18
Reducing medical cannabis use risk among Veterans: A descriptive study	18
Best practices for community-based overdose education and naloxone distribution programs: results from using the Delphi approach	18
An evaluation of first responders’ intention to refer to post-overdose services following SHIELD training	18
“They make it too hard and too many hoops to jump”: system and organizational barriers to drug treatment during epidemic rates of opioid overdose	18
Total systems failure: police officers’ perspectives on the impacts of the justice, health, and social service systems on people who use drugs	17
Feasibility of paying people who use drugs cash to distribute naloxone within their networks	17
Challenges in legitimizing further measures against smoking in jurisdictions with robust infrastructure for tobacco control: how far can the authorities allow themselves to go?	16
'It’s not going to be a one size fits all': a qualitative exploration of the potential utility of three drug checking service models in Scotland	16
The joy and pain of being a harm reduction worker: a qualitative study of the meanings about harm reduction in Brazil	16
The impact of supported accommodation on health and criminal justice outcomes of people released from prison: a systematic literature review	15
Effects of a social network intervention on HIV seroconversion among people who inject drugs in Ukraine: moderation by network gender composition	15
“I feel like marijuana is the only drug that wouldn’t kill me”: perceptions of cannabis use in previously incarcerated Black men who have sex with other men	15
Switching behavior and changes in smoking behavior by menthol cigarette preference and menthol heated tobacco product use among adults in the United States who smoke cigarettes: an actual use study	15
Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years	15
The “goldfish bowl”: a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting	15
International harm reduction indicators are still not reached: results from a repeated cross-sectional study on drug paraphernalia distribution in Germany, 2021	15

Effect of Massachusetts House Bill No. 4196 on electronic cigarette use: a mixed-methods study	15
Creating safe, inclusive spaces for hospital-based health care staff and people who use drugs: an exploratory qualitative study in Vancouver, Canada	15
Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis	15
Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER)	15
Correction: The managers’ perspectives on service providing in women’s harm reduction centers during the COVID-19 pandemic: mixed method study	15
Involuntary discharge from drug or alcohol treatment programs in Vancouver, Canada	15
Epidemic of HIV infection among persons who inject drugs in mainland China: a series, cross-sectional study	15
The associations between social determinants of health, mental health, substance-use and recidivism: a ten-year retrospective cohort analysis of women who completed the connections programme in Austra	15
Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study	15
Feasibility, acceptability, and perceived usefulness of a community-evidence-based harm reduction intervention for sexualized stimulant use among Mexican gay, bisexual, and other men who have sex with	14
Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience	14
Prevalence and predictors of condom use among people who inject drugs in Georgia	14
Managing high-risk behaviours and challenges to prevent housing loss in permanent supportive housing: a rapid review	14
Quantifying the size and characteristics of a population of people who use drugs on the reservation lands of a tribal nation in the southern plains (USA)	14
Law enforcement and syringe services program implementation in rural counties in Kentucky: a qualitative exploration	14
Injecting drugs alone during an overdose crisis in Vancouver, Canada	14
HIV incidence and associated risk factors in female spouses of men who inject drugs in Pakistan	13
Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data	13
Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study	13
Preloading with drugs before entry to the nighttime entertainment district: presentation, intoxication rates, and effects of police presence during assessment	13
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review	13
Food access among people who inject drugs in West Virginia	13
Heroin pipe distribution to reduce high-risk drug consumption behaviors among people who use heroin: a pilot quasi-experimental study	13
Correction: Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach	13
Correction: A reduced exposure heated tobacco product was introduced then abruptly taken off United States shelves: results from a tobacco harm reduction natural experiment	13
Development, acceptability and feasibility of a personalised, behavioural intervention to prevent bacterial skin and soft tissue infections among people who inject drugs: a mixed-methods Person-Based	13
Gambling treatment service providers’ views about contingency management: a thematic analysis	12
Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study	12
Differentiating the role of alcohol in young men’s use of substances with sex: A qualitative study	12
Ultrasound-guided phlebotomy in primary care for people who inject drugs	12
A scoping review on barriers and facilitators to harm reduction care among youth in British Columbia, Canada	12
Oral health risks in adults who use electronic nicotine delivery systems and oral nicotine pouches: a critical review of the literature and qualitative synthesis of the available evidence	12
Uptake of COVID-19 vaccination among people who inject drugs	12
The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services	12
Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review	12
How an emergency department is organized to provide opioid-specific harm reduction and facilitators and barriers to harm reduction implementation: a systems perspective	12
“I don’t let anybody die on my watch”: perspectives on the intersection of community overdose response and emergency medical services among people who use drugs in Seattle, WA	12
Perspectives of U.S. harm reduction advocates on persuasive message strategies	12
Come back when you’re infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 2023	12
A Case report of a continuous ambulatory drug delivery (CADD) pump to deliver opioid agonist treatment in an acute care setting	12
The impact of JUUL market entry on cigarette sales: evidence from a major chain retailer in Canada	11
The quality of health information provided on web sites selling cannabis to consumers in Canada is poor	11
“We were building the plane as we were flying it, and we somehow made it to the other end”: syringe service program staff experiences and well-being during the COVID-19 pandemic	11
The potential of new nicotine and tobacco products as tools for people who smoke to quit combustible cigarettes – a systematic review of common practices and guidance towards a robust study protocol t	11
‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts	11
Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019–April 2020	11
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa	11
The challenges, opportunities and strategies of engaging young people who use drugs in harm reduction: insights from young people with lived and living experience	11
Correction: Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia	11
Relational anonymity in reducing the harms of illicit drug use: accounts of users of dark web- and street-based services in Finland	11
The motives and methods of methamphetamine and ‘heroin’ co-use in West Virginia	11
NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users	11
HIV prevalence and continuum of care among incarcerated people in Iran from 2010 to 2017	11
High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment	11
The hazardous (mis)perception of Self-estimated Alcohol intoxication and Fitness to drivE—an avoidable health risk: the SAFE randomised trial	11
Challenges for the implementation of injectable opioid agonist treatment: a scoping review	11
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs	11
Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse	11
Differences by race and ethnicity in drug use patterns, harm reduction practices and barriers to treatment among people who use drugs in Rhode Island	10
Challenges of the COVID-19 pandemic on women’s HIV harm reduction centers: a mixed-methods study	10
Substance use and overdose risk: documenting the perspectives of formerly incarcerated persons in the Fraser East region of BC	10
The high frequency of alcohol advertising during televised English Premier League football games shown in Ethiopia	10
Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context	10
Vancouver’s Alcohol Knowledge Exchange: lessons learned from creating a peer-involved alcohol harm reduction strategy in Vancouver’s Downtown Eastside	10
Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis	10
Exploring the perception of key stakeholders toward khat policy approaches in Ethiopia: a qualitative study	10
“I don’t want to die”: a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies	10
The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study	10
Harm reduction must be recognised an essential public health intervention during crises	10
Selling sex in the context of substance use: social and structural drivers of transactional sex among men who use opioids in Maryland	10
Opioid overdose prevention education in Texas during the COVID-19 pandemic	10
Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews	10
Exploring substance use disorder discussions in Native American communities: a retrospective Twitter infodemiology study	10
Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017–2019	10
Therapy of chronic hepatitis C in people who inject drugs: focus on adherence	10
Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care	10
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya	10
Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations	9
Women, gender and drugs: between research and action	9
Muslims perceptions of safe alcohol use: a qualitative study in the Gulf Council Cooperation countries	9

Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection	9
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study	9
Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia	9
The impact of psychostimulant use on office based buprenorphine treatment retention	9
Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review	9
Suicidal thoughts and behaviors among untreated illicit substance users: a population-based study	9
Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019–2021: a repeat cross-sectional study	9
The relationship between police contacts for drug use-related crime and future arrests, incarceration, and overdoses: a retrospective observational study highlighting the need to break the vicious cyc	9
Cohort profile: the Kyrgyzstan InterSectional Stigma (KISS) injection drug use cohort study	9
Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report	9
Overdose responses among rural people who use drugs: A multi-regional qualitative study	9
Mandatory verses voluntary self-tests for new online casino customers: effect on engagement, quality, gambling behavior and use of responsible gambling measures	9
Impact of tobacco and/or nicotine products on health and functioning: a scoping review and findings from the preparatory phase of the development of a new self-report measure	9
Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study	9
Signals of increasing co-use of stimulants and opioids from online drug forum data	9
A longitudinal study of naloxone opioid overdose awareness and reversal training for first-year medical students: specific elements require reinforcement	8
Implementing Canada’s first national virtual phone based overdose prevention service: lessons learned from creating the National Overdose Response Service (NORS)	8
Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities	8
A confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA	8
An exploration of desired abstinent and non-abstinent recovery outcomes among people who use methamphetamine	8
COVID-19 vaccination intention among people who use drugs in France in 2021: results from the international community-based research program EPIC	8
CENTER-ing Black voices: incorporating lived experience across the research process to advance equity in drug treatment and outcomes	8
Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study	8
Community pharmacists’ attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey	8
Patterns of care contacts in the final year of life among opioid overdose fatalities in southern Sweden: a latent class analysis	8
Dealing with low access to harm reduction: a qualitative study of the strategies and risk environments of people who use drugs in a small Swedish city	8
Ups and downs of addiction harm reduction in Iran: key insights and implications for harm reduction policy and policing	8
“No-one just does drugs during business hours!”: evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia	8
Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities	8
A scoping review of implementation considerations for harm reduction vending machines	8
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive ev	8
Balancing public health and privacy rights: a mixed-methods study on disclosure obligations of people living with HIV to their partners in China	8
A cultural and political difference: comparing the racial and social framing of population crack cocaine use between the United States and France	8
Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting	8
Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder	8
Comprehensive drug policies increase trust in local government: an analysis of authorities’ and residents’ perspectives in rural US Appalachian and Midwestern counties	8
‘Why would we not want to keep everybody safe?’ The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland	8
Reducing the harms of cannabis use in youth post-legalization: insights from Ontario youth, parents, and service providers	8
“As safe as possible”: a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids	8
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)	8
Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the O	7
Estimating lung cancer risk from e-cigarettes and heated tobacco products: applications of a tool based on biomarkers of exposure and of potential harm	7
Correction: Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugs	7
Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery	7
An individual-based dynamic model to assess interventions to mitigate opioid overdose risk	7
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19	7
Self-exclusion and breaching of self-exclusion from gambling: a repeated survey study on the development of a nationwide self-exclusion service	7
Fanning the flame: analysing the emergence, implications, and challenges of Australia’s de facto war on Nicotine	7
Intention to get naloxone among patients prescribed opioids for chronic pain	7
Correction: Increasing access to screening for blood-borne viruses and sexually transmissible infections for Aboriginal and Torres Strait Islander Australians: evaluation of the Deadly Liver Mob progr	7
Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder	7
Association between socioeconomic and motherhood characteristics with receiving community-based treatment services among justice-involved young female drug users: a retrospective cohort study in Taiwa	7
Perceived harms and protective behavioural strategies among khat chewers: a qualitative study in Jimma, Ethiopia	7
Assessment of harm reduction receipt and infectious diseases outcomes in United States Veterans with opioid use disorder and history of injection drug use	7
A randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI® stick ENDS compared with combustible cigarettes and a comparator ENDS in adult smokers	7
The theory of preloading: A cognitive-behavioural motivational model	7
Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department	7
Measuring sustainability of opioid agonist therapy programs in the context of transition from Global Fund support	7
The impact of Taiwan’s implementation of a nationwide harm reduction program in 2006 on the use of various illicit drugs: trend analysis of first-time offenders from 2001 to 2017	7
Substance use, injection risk behaviors, and fentanyl-related overdose risk among a sample of PWID post-Hurricane Maria	7
Interaction and conflict between outreach workers and research officers in implementing collaborative action research in the field of harm reduction: a qualitative study	7
How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study	6
Correlates of fentanyl preference among people who use drugs in Rhode Island	6
Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach	6
Unpacking the Effects of Decriminalization: Understanding Drug Use Experiences and Risks among Individuals Who Use Drugs in British Columbia	6
Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project	6
Identifying the facilitators of Iran’s alcoholic beverage black market and presenting solutions for harm reduction: a qualitative document analysis	6
Assessing experts’ perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State	6
How a sample of English stop smoking services and vape shops adapted during the early COVID-19 pandemic: a mixed-methods cross-sectional survey	6
Acute pain and self-directed discharge among hospitalized patients with opioid-related diagnoses: a cohort study	6
“I don’t go to funerals anymore”: how people who use opioids grieve drug-related death in the US overdose epidemic	6
High levels of used syringe use and unsafe sex among people who inject drugs in Kumasi, Ghana: an urgent call for a comprehensive harm reduction approach	6
Harm reduction in the Heartland: public knowledge and beliefs about naloxone in Nebraska, USA	6
An approach designed to fail deaf children and their parents and how to change it	6
Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky	6
Opioid-specific harm reduction in the emergency department: how staff provide harm reduction and contextual factors that impact their capacity to engage in harm reduction practice	6
Opioid-related harms and experiences of care among people in justice settings in New South Wales, Australia: evidence from the National Ambulance Surveillance System	6
Correction to: An exploratory non-randomized study of a 3-month electronic nicotine delivery system (ENDS) intervention with people accessing a homeless supported temporary accommodation service (STA)	6
A qualitative study of benzodiazepine/z-drug and opioid co-use patterns and overdose risk	6
People who inject oral morphine favor experimentation with injectable opioid substitution	6
Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada	6
A qualitative investigation of the feasibility and acceptability of lower risk gambling guidelines	6
Treatment non-adherence among methadone maintenance patients and associated factors: a multicenter, cross-sectional study in Vietnam	6
Community-based respondent-driven sampling as a strategy for drug use surveillance in a large French urban area	6
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021	6
Prevalence and correlates of using opioids alone among individuals in a residential treatment program in Michigan: implications for overdose mortality prevention	6
Estimation of the global number of e-cigarette users in 2020	5
Peer-led safer supply and opioid agonist treatment medication distribution: a case study from rural British Columbia	5
Improving hospital care for people who use drugs: deliberative process development of a clinical guideline for opioid withdrawal management	5
High-dose intravenous hydromorphone for patients who use opioids in the hospital setting: time to reduce the barriers	5
How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation	5
Community-Engaged Research Ethics Training (CERET): developing accessible and relevant research ethics training for community-based participatory research with people with lived and living experience	5
The fentanyl made me feel like I needed more methadone”: changes in the role and use of medication for opioid use disorder (MOUD) due to fentanyl	5
A realist review of best practices and contextual factors enhancing treatment of opioid dependence in Indigenous contexts	5
Attitudes and experiences with fentanyl contamination of methamphetamine: exploring self-reports and urine toxicology among persons who use methamphetamine and other drugs	5